The intracellular delivery of GRK2-specific peptide substrates may provide new opportunities for basic research into GRK2 and its biological roles in diagnosing and treating GRK2-related diseases, such as cancer and autoimmune disorders. The gene discussed is GRK2; the disease is autoimmune disease.